428 filings
Page 12 of 22
SC 13G/A
SPRC
SciSparc Ltd.
1 Feb 21
SciSparc / BIGGER CAPITAL FUND L P ownership change
5:02pm
6-K
SPRC
SciSparc Ltd.
28 Jan 21
Report of Foreign Private Issuer
9:36am
6-K
SPRC
SciSparc Ltd.
25 Jan 21
Special General Meeting of Shareholders
5:27pm
6-K
SPRC
SciSparc Ltd.
7 Jan 21
Report of Foreign Private Issuer
5:00pm
6-K
SPRC
SciSparc Ltd.
6 Jan 21
Report of Foreign Private Issuer
11:53am
6-K
SPRC
SciSparc Ltd.
5 Jan 21
Therapix Biosciences and Cyntar Ventures Entered a Non-Binding Letter of Intent for the Distribution of TheraPEA in Canada
9:12am
6-K
SPRC
SciSparc Ltd.
31 Dec 20
Report of Foreign Private Issuer
2:02pm
6-K
SPRC
SciSparc Ltd.
15 Dec 20
Report of Foreign Private Issuer
10:55am
SC 13G
SPRC
SciSparc Ltd.
9 Dec 20
Therapix Biosciences / EIDE ROBERT J ownership change
5:11pm
6-K
SPRC
SciSparc Ltd.
8 Dec 20
Therapix Biosciences Announces Upgrade to OTCQB Venture Market
9:36am
SC 13D/A
L.I.A. Pure Capital Ltd
3 Dec 20
Therapix Biosciences / L.I.A. Pure Capital ownership change
10:43am
6-K
SPRC
SciSparc Ltd.
2 Dec 20
Special General Meeting of Shareholders
4:02pm
6-K
SPRC
SciSparc Ltd.
2 Dec 20
Therapix Biosciences to Collaborate with The University of Calgary to Further Examine its Proprietary Drug Candidate THX-160 for Pain
9:25am
SC 13G
SPRC
SciSparc Ltd.
30 Nov 20
Therapix Biosciences / BIGGER CAPITAL FUND L P ownership change
5:01pm
6-K
SPRC
SciSparc Ltd.
24 Nov 20
Therapix Biosciences Announces Pricing of $4.2 Million Offering
1:13pm
424B4
SPRC
SciSparc Ltd.
20 Nov 20
Prospectus supplement with pricing info
4:43pm
F-1MEF
SPRC
SciSparc Ltd.
19 Nov 20
Registration statement to add securities to prior F-1 registration
9:33am
EFFECT
SPRC
SciSparc Ltd.
19 Nov 20
Notice of effectiveness
12:15am
CORRESP
SPRC
SciSparc Ltd.
16 Nov 20
Correspondence with SEC
12:00am
CORRESP
SPRC
SciSparc Ltd.
12 Nov 20
Correspondence with SEC
12:00am